MONTREAL, March 25 /CNW Telbec/ - Akela Pharma Inc. (TSX: "AKL"), a drug
development company focused on developing therapies for the inhalation and
pain markets, today announced that it will report financial results for the
fourth quarter and fiscal 2007 ended December 31, 2007 on Monday March 31,
2008.
